| Product NDC: | 13533-603 |
| Proprietary Name: | Thrombate III |
| Non Proprietary Name: | antithrombin III |
| Active Ingredient(s): | & nbsp; antithrombin III |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13533-603 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103196 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19911230 |
| Package NDC: | 13533-603-25 |
| Package Description: | 1 KIT in 1 CARTON (13533-603-25) * 10 mL in 1 VIAL, GLASS * 10 mL in 1 VIAL, GLASS |
| NDC Code | 13533-603-25 |
| Proprietary Name | Thrombate III |
| Package Description | 1 KIT in 1 CARTON (13533-603-25) * 10 mL in 1 VIAL, GLASS * 10 mL in 1 VIAL, GLASS |
| Product NDC | 13533-603 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | antithrombin III |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19911230 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |